Navigation Links
Managing Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics educational webinar hosted by Nanosphere and Xtalks
Date:7/18/2013

Northbrook, IL (PRWEB) July 18, 2013

NORTHBROOK, IL—July 18, 2013—Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, together with Xtalks, will host an interactive webinar entitled: “Each Hour Counts: Improving Management of Carbapenem-Resistant Enterobacteriaceae (CRE) and Other Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics.” The complimentary webinar will be held on Wednesday, August 14, 2013 at 1:00pm EDT.

To register for this event, please visit: http://xtalks.com/eachhourcounts.ashx.

Each year in the United States, there are more than 1.5 million hospital stays associated with bloodstream infections and septicemia, resulting in nearly 100,000 deaths and over $15 billion in healthcare costs [1].

Treatment of these serious bacterial infections in clinical practice is often complicated by antibiotic resistance, which has been associated with prolonged hospital stays, higher health care costs and increased mortality. The recent emergence of CREs is especially troubling, as there are very few antibiotic alternatives available to treat these bacteria.

In this webinar, Karen Carroll, M.D., Professor of Pathology and Medicine at Johns Hopkins University School of Medicine; Nathan Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin; and Debra Goff, PharmD, Clinical Associate Professor at The Ohio State University College of Pharmacy, will discuss strategies for managing antibiotic-resistant bacterial infections. These recognized leaders will review new molecular technologies that identify bacteria and corresponding antibiotic resistance more rapidly than traditional culture methods, and may enable earlier optimization of antibiotic therapy, thereby improving patient outcomes.

Registrants may qualify to receive a P.A.C.E. continuing education credit for this webinar.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere’s product portfolio includes the Verigene Gram-Positive Blood Culture (BC-GP) (510(k) cleared; CE Mark) and Gram-Negative Blood Culture (BC-GN) (RUO; IUO; CE Mark) Tests. Nanosphere is based in Northbrook, IL.

For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting(at)nanosphere(dot)us or visit http://www.nanosphere.us.

Contacts

Investors:
Roger Moody, Chief Financial Officer
Nanosphere, Inc.
+1 847-400-9021
rmoody(at)nanosphere(dot)us

Media:
Lindsey Saxon, Director of Communications
Nanosphere, Inc.
+1 847-400-9173
lsaxon(at)nanosphere(dot)us

Karen Lim, Director of Member Services
Xtalks
+1 416-977-6555 ext 227
clientservices(at)xtalks(dot)com

[1] Elixhauser, A. (Agency for Healthcare Research and Quality), Friedman, B. (Agency for Healthcare Research and Quality) and Stranges, E. (Thomson Reuters). Septicemia in U.S. Hospitals, 2009. HCUP Statistical Brief #122. October 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf

Read the full story at http://www.prweb.com/releases/2013/7/prweb10925090.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
2. Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
3. New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks
4. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
5. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
6. Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria
7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
8. New laboratory method uses mass spectrometry to rapidly detect staph infections
9. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
10. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
11. Ondine Biomedical’s MRSAID(TM) Technology Demonstrates Successful Results in Reducing Surgical Site Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):